BIO-MEDICINE: Dutasteride (Avodart), a commonly prescribed drug to treat benign prostatic hyperplasia, has been shown to lower the risk of prostate cancer by 23 percent in men with an increased risk of the disease, according to results of an international clinical trial presented yesterday at the American Urological Association annual meeting in Chicago. READ MORE>
PROSTATE RESEARCH: Drug used for enlarged prostate also reduces cancer risk
April 29, 2009 by Jim Tucker
Posted in Enlarged prostate, PROSTATE CANCER, PROSTATE RESEARCH, Treatment news | Tagged benign prostatic hyperplasia, cancer research, Dutasteride (Avodart), Enlarged prostate, prostablog, prostate, PROSTATE CANCER, prostate cancer treatments, prostate treatment, prostate treatment debate | Leave a Comment
Blog Stats
- 295,394 hits
Search
MY PROSTATE STORY
Prostate inquiry
Prostate websites
Prostablog RSS – click here
- Still here, still clear – 2020 June 24, 2020
- PSA treachery hits close to home May 18, 2019
- Coming up to a decade clear June 4, 2018
PROSTABLOG pages
Category cloud
AFTER EFFECTS Biochemical recurrence Biopsy Brachytherapy Checkups Diagnosis Dietary intervention Doctors' advice Erectile function FUND RAISING Govt prostate policy Hormone therapy Incontinence Natural remedies New prostate drugs New tests Prostate blogs PROSTATE CANCER Prostate claims Prostate prognosis PROSTATE RESEARCH PROSTATE RISKS PSA tests Public health system Radical prostatectomy Radiotherapy Rowing 4 Prostate Screening debate Treatment debate Treatment newsCOMMENTS
Leave a Reply